AGT researchers net $4.4m NIH grant
Thursday, 03 July, 2003
Researchers associated with Victorian-based AGT Biosciences have landed a $AUD4.4 million grant from the US National Institutes of Health to fund its human gene discovery research.
The grant, awarded over a period of five years, will be shared between Prof Ahmed Kissebah of the Medical College of Wisconsin, Dr John Blangero of AGT and the Texas-based Southwest Foundation for Biomedical Research, and the AGT team at Deakin University, Geelong.
Prof Greg Collier, AGT's CEO and managing director, said in a statement that the grant was a strong affirmation of AGT's approach to solving problems of complex human diseases.
He said the grant would support a trilateral collaboration between Kissebah (population genetics), Blangero's team (statistical genomics) and AGT's eXpress technology platform.
Researchers genetically engineer snake antivenom
An international team of researchers has used genetic engineering to create so-called...
Common medications linked to adverse breast cancer outcomes
An international study has found concerning evidence about the impact of a range of common...
Saliva-based biosensor could improve heart failure detection
Scientists have created a biosensor that can rapidly detect the heart failure biomarker S100A7 in...
